FTSE MIB
34.249,77 +310,02 (+0,91%) Dow Jones
38.239,66 +153,86 (+0,40%) Nasdaq
15.927,90 +316,14 (+2,03%) Nikkei 225
37.934,76 +306,28 (+0,81%) Petrolio
83,66 +0,09 (+0,11%) Bitcoin EUR
58.864,90 -1.310,96 (-2,18%)
Amedisys, Inc. (AMED)
Dopo ore:
| Chiusura precedente | 91,16 |
| Aperto | 91,00 |
| Denaro | 83,77 x 200 |
| Lettera | 98,73 x 200 |
| Min-Max giorno | 91,00 - 91,88 |
| Intervallo di 52 settimane | 73,10 - 96,44 |
| Volume | |
| Media Volume | 275.379 |
| Capitalizzazione | 2,999B |
| Beta (5 anni mensile) | 0,86 |
| Rapporto PE (ttm) | N/D |
| EPS (ttm) | -0,64 |
| Prossima data utili | 24 lug 2024 - 29 lug 2024 |
| Rendimento e dividendo (futuro) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | 97,78 |
GlobeNewswireAmedisys Recognizes Suicide Prevention Awareness Month and Promotes the 988 Suicide & Crisis Lifeline
BATON ROUGE, La., Aug. 31, 2023 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care in the home, is proud to recognize September as Suicide Prevention Awareness Month and join the efforts to raise awareness for suicide prevention and mental health. In support of this important cause, Amedisys is highlighting the 988 Suicide and Crisis Lifeline which makes it easier for individuals in crisis to access crucial resources and assistance.
- GlobeNewswire
Amedisys Reports Second Quarter 2023 Financial Results
BATON ROUGE, La., July 26, 2023 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and six-month periods ended June 30, 2023. Three-Month Periods Ended June 30, 2023 and 2022 Net service revenue decreased $4.9 million to $553.0 million compared to $557.9 million in 2022.Net loss attributable to Amedisys, Inc. of $80.3 million, which is inclusive of $125.5 million in costs associated with our merger transactions, compared to net income attributabl
- GlobeNewswire
Amedisys and Optum to Combine, Advancing Value-Based Care for Patients
BATON ROUGE, La., June 26, 2023 (GLOBE NEWSWIRE) -- Amedisys (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care, and Optum, a diversified health services company, have agreed to combine. The agreement calls for the acquisition of Amedisys’s outstanding common stock in an all-cash transaction for $101 per share. The combination of Amedisys with Optum unites two organizations dedicated to providing compassionate, value-based comprehensive care to patients and their fam
